Details of the event will follow in due course




Venue: TBA Hongo Campus, The University of Tokyo

Speakers

Jenny Molly

Senior Research Associate
Department of Chemical Engineering and Biotechnology
University of Cambridge

Dr Jenny Molloy is a Senior Research Associate at the University of Cambridge and a Group Leader at the International Centre for Genetic Engineering and Biotechnology (ICGEB), where she develops open source technologies for engineering biology and biomanufacturing. Prior to this she was the Programme Coordinator of the University of Cambridge Strategic Research Initiative in Synthetic Biology and the OpenPlant Synthetic Biology Research Center. She has an undergraduate degree from the University of Cambridge and a DPhil in Zoology from the University of Oxford focused on genetic control of dengue mosquitoes.
Jenny’s research is centered around local, distributed biomanufacturing of enzymes to enhance global capacity for biological research and advance applications in health and sustainability. Ongoing projects include developing open source DNA toolkits for recombinant protein expression using synthetic biology-based platform technologies, high-quality protein purification in low-resource contexts, open source microbial strain engineering, CRISPR-based molecular diagnostics for infectious diseases and enzyme-based carbon capture and upcycling.
Jenny is a former Fellow and Member of the World Economic Forum Global Future Council on Synthetic Biology and since 2015 she has co-founded four social enterprises and nonprofits making open source tools more accessible to researchers and building communities for open source tool developers. She currently sits on the board of the US non-profit Open Science Hardware Foundation, the UK non-profit Beneficial Bio and the Kenyan NGO ISAAA Africenter.

Makiko Matsuo

The University of Tokyo

Mark Howarth

Sheild Professor of Pharmacology
Department of Pharmacology
University of Cambridge

Mark Howarth is the Sheild Professor in Cambridge University Department of Pharmacology. His group has developed a range of protein superglues that are widely used in academia and industry. For this work he received the Royal Society of Chemistry Norman Heatley Award for chemical biology. He co-founded the vaccine company SpyBiotech and 9 alumni from his lab have spun out their own companies. He is also the Translational Champion for his Department, working to develop entrepreneurship and increase collaborations with companies around the world.